Commentary: tackling the challenges of developing targeted therapies for cancer.
Publication
, Journal Article
Schilsky, RL; Allen, J; Benner, J; Sigal, E; McClellan, M
Published in: The oncologist
January 2010
Duke Scholars
Published In
The oncologist
DOI
EISSN
1549-490X
ISSN
1083-7159
Publication Date
January 2010
Volume
15
Issue
5
Start / End Page
484 / 487
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Drug Design
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Schilsky, R. L., Allen, J., Benner, J., Sigal, E., & McClellan, M. (2010). Commentary: tackling the challenges of developing targeted therapies for cancer. The Oncologist, 15(5), 484–487. https://doi.org/10.1634/theoncologist.2010-0079
Schilsky, Richard L., Jeff Allen, Joshua Benner, Ellen Sigal, and Mark McClellan. “Commentary: tackling the challenges of developing targeted therapies for cancer.” The Oncologist 15, no. 5 (January 2010): 484–87. https://doi.org/10.1634/theoncologist.2010-0079.
Schilsky RL, Allen J, Benner J, Sigal E, McClellan M. Commentary: tackling the challenges of developing targeted therapies for cancer. The oncologist. 2010 Jan;15(5):484–7.
Schilsky, Richard L., et al. “Commentary: tackling the challenges of developing targeted therapies for cancer.” The Oncologist, vol. 15, no. 5, Jan. 2010, pp. 484–87. Epmc, doi:10.1634/theoncologist.2010-0079.
Schilsky RL, Allen J, Benner J, Sigal E, McClellan M. Commentary: tackling the challenges of developing targeted therapies for cancer. The oncologist. 2010 Jan;15(5):484–487.
Published In
The oncologist
DOI
EISSN
1549-490X
ISSN
1083-7159
Publication Date
January 2010
Volume
15
Issue
5
Start / End Page
484 / 487
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Drug Design
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis